Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,227 | $7,234 | $5,358 | $4,291 |
| - Cash | $242 | $399 | $276 | $869 |
| + Debt | $1,417 | $1,454 | $1,369 | $1,251 |
| Enterprise Value | $6,402 | $8,289 | $6,450 | $4,673 |
| Revenue | $705 | $788 | $587 | $810 |
| % Growth | -10.5% | 34.1% | -27.5% | – |
| Gross Profit | $694 | $779 | $573 | $800 |
| % Margin | 98.4% | 98.8% | 97.6% | 98.7% |
| EBITDA | -$354 | -$236 | -$228 | -$5 |
| % Margin | -50.2% | -29.9% | -38.8% | -0.6% |
| Net Income | -$454 | -$366 | -$270 | -$29 |
| % Margin | -64.4% | -46.5% | -45.9% | -3.5% |
| EPS Diluted | -3.04 | -2.56 | -1.9 | -0.2 |
| % Growth | -18.8% | -34.7% | -850% | – |
| Operating Cash Flow | -$501 | -$308 | -$274 | $31 |
| Capital Expenditures | -$45 | -$28 | -$20 | -$18 |
| Free Cash Flow | -$546 | -$336 | -$294 | $13 |